STAT
SEPTEMBER 14, 2023
The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly list patents for brand-name medicines in a Food and Drug Administration registry, the latest effort by the federal government to scrutinize patent moves by drugmakers.
STAT
MARCH 21, 2023
government to remove the key negotiator working on a free trade agreement with the Indian government because of his previous ties to a major pharmaceutical company. More than 200 civil society and patient advocacy groups are urging the U.K. Now, the groups are upset that the involvement of Harjinder Kang, the U.K.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Guardian - Pharmaceutical Industry
FEBRUARY 7, 2024
Britain is pushing for patent changes that could increase the cost of Indian generic drugs, diverting more of the NHS budget to big pharma India is known as the “ pharmacy of the world ”, supplying vital generic medicines at low prices to health services including the NHS. They spend billions on research and recoup billions.
European Pharmaceutical Review
FEBRUARY 26, 2024
Medicine indication extensions recommended by the CHMP The committee recommended extensions of indications for six EU-approved medicines, including: CARVYKTI ® ▼ (ciltacabtagene autoleucel; cilta-cel)* , Keytruda and Reblozyl*. These products were designated as an orphan medicine during their development.
pharmaphorum
DECEMBER 15, 2020
During this time, the role and responsibility of generics suppliers and manufacturers has been brought into stark perspective as one of the leading contributors in this industry-wide effort. The pandemic has further highlighted how research is not strictly limited to large, “innovator” pharmaceutical companies.
European Pharmaceutical Review
MARCH 14, 2023
The CJEU stressed that identical medicinal products are not those that are only therapeutically equivalent (as generics are to reference products), but they should be identical in all respects. He has been advising pharmaceutical companies and healthcare providers for a number of years.
pharmaphorum
AUGUST 25, 2022
The new partnership “marks a major milestone in Sonde Health’s growth and evolution,” according to the company’s chief executive David Liu.
Expert insights. Personalized for you.
132 
Let's personalize your content